These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8846747)

  • 1. Effects of bifemelane hydrochloride on plasma neuropeptide Y, 3-methoxy-4-hydroxyphenylethylene glycol and 5-hydroxy-indole acetic acid concentrations in patients with cerebral infarction.
    Koide S; Onishi H; Hashimoto H; Kai T; Katayama M; Yamagami S
    Drugs Exp Clin Res; 1995; 21(5):175-80. PubMed ID: 8846747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
    Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
    Gjerris A; Widerlöv E; Werdelin L; Ekman R
    J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone in the treatment of psychotic depression.
    Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical observations during treatment of depression with electroacupuncture: a pilot study.
    Pohl A; Nordin C
    Hum Psychopharmacol; 2002 Oct; 17(7):345-8. PubMed ID: 12415553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
    Hou C; Jia F; Liu Y; Li L
    Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-rated aggression and cerebral monoaminergic turnover. Sex differences in patients with persistent depressive disorder.
    Prochazka H; Agren H
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):185-92. PubMed ID: 12910349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review.
    Yoshimura R; Nakamura J; Shinkai K; Ueda N
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):611-6. PubMed ID: 15276685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Antidepressants on Neuropeptide Y in Patients with Depression and Anxiety.
    Ozsoy S; Olguner Eker O; Abdulrezzak U
    Pharmacopsychiatry; 2016 Jan; 49(1):26-31. PubMed ID: 26789271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
    Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
    Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
    Zimmerman M; Posternak MA; Chelminski I
    J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

  • 17. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
    Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J
    Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
    Mitani H; Shirayama Y; Yamada T; Kawahara R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls.
    Held K; Antonijevic I; Murck H; Kuenzel H; Steiger A
    Psychoneuroendocrinology; 2006 Jan; 31(1):100-7. PubMed ID: 16112814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.